Yu Xia - 02 Jan 2024 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Director
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Yu Xia
Issuer symbol
SMMT
Transactions as of
02 Jan 2024
Transactions value $
$0
Form type
4
Filing time
04 Jan 2024, 16:19:53 UTC
Previous filing
14 Feb 2024
Next filing
06 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +35K 35K 02 Jan 2024 Common Stock 35K $2.64 Direct F1, F2
transaction SMMT Stock Option (right to buy) Award +200K +571.43% 235K 02 Jan 2024 Common Stock 200K $2.64 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2024. The shares underlying the option shall vest in four equal quarterly installments on March 31, June 30, September 30 and December 31 of the year of grant, subject to the director remaining as a non-salaried director on each such vesting date.
F2 Not applicable.
F3 The option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on January 2, 2025.